13th August 2024
BNF for Children
This update contains 4 significant changes, 1 dose change, and…
Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
Close
Close
Contact our team to see how our services can directly help you.
Close
Access our useful resources today to help your organisation realise the benefits of subscribing to Psychotropic Drug Directory through MedicinesComplete. Including patient case studies covering everyday clinical scenarios, and an on-demand webinar showing how to navigate independent information, advice, and commentary on psychotropic drugs.
Close
Register for this live webinar to learn how to use Psychotropic Drug Directory through MedicinesComplete in clinical practice.
Close
Learn more about how we're celebrating two decades of MedicinesComplete.
Close
Practical and evidence-based, BNF for Children is the only child-focused drug formulary in the world that is both independent, and has rigorous, accredited content creation processes.
Relied on by health professionals who prescribe, dispense, and administer medicines for childhood disorders, BNF for Children supports confident decision-making at the point of care. Including best practice guidelines and advice from a network of paediatric experts. The process is overseen by a Paediatric Formulary Committee.
Our knowledge products are regularly updated online through MedicinesComplete
13th August 2024
This update contains 4 significant changes, 1 dose change, and…
13th August 2024
This update contains 4 significant changes, 1 dose change, and 3 new monographs.
Significant Changes:
•Immunisation schedule: updated guidance for immunisation against influenza.
•Influenza vaccine: updated guidance for immunisation.
•Medical emergencies in the community: updated guidance on the use of salbutamol in the management of acute asthma.
•Topical corticosteroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal Reactions [MHRA/CHM advice] (advice in relevant monographs; see example in betamethasone).
Dose Changes:
•Salbutamol [update to dosing for asthma; prophylaxis of allergen-or-exercise-induced bronchospasm; and exacerbation of reversible airways obstruction].
New Monographs:
•Biktarvy® [bictegravir with emtricitabine and tenofovir alafenamide].
•Finlee® [dabrafenib].
•Spexotras® [trametinib].
9th July 2024
This update contains 7 significant changes, 1 new preparation, and…
9th July 2024
This update contains 7 significant changes, 1 new preparation, and 1 deleted monograph.
Significant Changes:
New preparations:
Deleted Monographs:
11th June 2024
This update contains 4 significant changes, 5 dose changes, 5…
11th June 2024
This update contains 4 significant changes, 5 dose changes, 5 new monographs and 1 deleted monograph.
Significant Changes:
Dose Changes:
New Monographs:
Deleted Monographs:
14th May 2024
This update contains 8 significant changes, 3 dose changes, 3…
14th May 2024
This update contains 8 significant changes, 3 dose changes, 3 new monographs, 1 new preparation and 2 deleted monographs.
Significant Changes:
Dose Changes:
New Monographs:
New Preparations: Otinova® [aluminium acetate].
Deleted Monographs: Chloroquine with proguanil; Proguanil hydrochloride.
9th April 2024
This update contains 4 significant changes, 2 new monographs, 1…
9th April 2024
This update contains 4 significant changes, 2 new monographs, 1 new preparation, 1 deleted monograph and 1 deleted preparation.
Significant Changes:
New Monographs:
New Preparations: Etacortilen® eye drops [dexamethasone].
Deleted Monographs: Benzoin tincture, compound.
Deleted Preparations: Hibitane® Plus 5% concentrate solution [chlorhexidine].
12th March 2024
This update contains 4 significant changes, 1 new monograph and…
12th March 2024
This update contains 4 significant changes, 1 new monograph and 1 deleted monograph.
Significant Changes:
New Monographs:
Deleted Monographs: Cinchocaine hydrochloride with fluocortolone caproate and fluocortolone pivalate.
Access BNF for Children through MedicinesComplete today.
Contact us now for pricing and access information.
BNF content is copyright © BMJ Publishing Group Ltd and Royal Pharmaceutical Society of Great Britain. BNFC content is copyright © BMJ Publishing Group Ltd, Royal Pharmaceutical Society of Great Britain, RCPCH Publications. All rights reserved.
A significant investment from National Institute for Health and Care Excellence (NICE) ensures that, with our partners BMJ Group and Royal College of Paediatrics and Child Health, we support NHS health professionals in the UK with unlimited access to BNF content online through MedicinesComplete and via the BNF + BNFC app.
$79.00
Info$99.00
InfoSee all our printed publications in the Shop.
Instant online access to our essential knowledge 24/7
The Royal Pharmaceutical Society’s official journal
Trusted knowledge and revision for tomorrow’s pharmacists
High impact research in pharmaceutical sciences